Michael Kleinrock, of The IQVIA Institute for Human Data Science, will moderate a panel of launch and market access experts, as they discuss how biotech companies have addressed some key challenges to achieve launch success. Specific points will include an assessment of the overall outlook, what makes launches excellent, how to determine your optimal strategy, and questions that need to be addressed when deciding whether to launch or to partner. Live: Wednesday, Oct. 23, 2019 at 10am EDT On demand available after airing until Oct. 23, 2020 Register free
Register free: http://www.pharmexec.com/pe_w/trends
Event Overview:
For biotech companies, the decision to partner or launch on your own will define your long-term success. Historically, the decision to sell to a larger company for launch was the best strategy. Today, more biotech companies than ever are successfully launching on their own. What’s behind this trend and what’s driving their success?
In this webinar, Michael Kleinrock, Research Director at The IQVIA Institute for Human Data Science, will moderate a panel of launch and market access experts as they discuss how biotech companies have resolved some of their key challenges to enable launch success. Specific points of the discussion will include:
Key Learning Objectives:
Speakers: Michael Kleinrock, Research Director, IQVIA Institute for Human Data Science
Sarah Rickwood, Vice President, European Thought Leadership, IQVIA
David Wolter, Vice President, Consulting, IQVIA
Adam Sohn, Vice President, IQVIA
Time and Date: Wednesday, Oct. 23, 2019 at 10am EDT
On demand available after airing until Oct. 23, 2020
Sponsor: IQVIA Biotech
Register free: http://www.pharmexec.com/pe_w/trends